The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations

Neuroscience Letters

Volumn 342, Issue 1-2, 2003, Pages 114-118

  D'Andrea, Michael R ^a   Reiser, Patti A ^a   Polkovitch, Deborah A ^a   Gumula, Norah A ^a   Branchide, Barbara ^a   Hertzog, Brenda M ^a   Schmidheiser, Danielle ^a   Belkowski, Stanley ^a   Gastard, Myriam C ^a   Andrade Gordon, Patricia ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Alzheimer's disease; Amyloid plaques; A 42; Formic acid; Immunohistochemistry; Intracellular amyloid; Neurons

Indexed keywords

AMYLOID; FORMIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; BRAIN TISSUE; CELL TYPE; CLINICAL OBSERVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EPENDYMA CELL; FEMALE; HEAT TREATMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MONOCYTE; NERVE CELL; PRIORITY JOURNAL; TECHNIQUE; VASCULAR SMOOTH MUSCLE;

EID: 0037448062     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00252-0     Document Type: Article

References (19)

1. Cammarata S., Mancardi G., Tabaton M. Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease. Neurosci. Lett. 115:1990;351-355.
2. Cummings B.J., Mason A.J., Kim R.C., Sheu P.C., Anderson A.J. Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging. Neurobiol. Aging. 23:(3):2002;161-170.
3. D'Andrea M.R., Nagele R.G. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in Alzheimer's disease brains. Biotech. & Histochem. 77:(2):2002;95-103.
4. D'Andrea M.R., Nagele R.G., Gumula N.A., Reiser P.A., Polkovitch D.A., Hertzog B.M., Andrade-Gordon P. Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci. Lett. 323:(1):2002;45-49.
5. D'Andrea M.R., Nagele R.G., Lee D.H.S., Wang H.-Y. Targeting intracellular Aβ for Alzheimer's disease drug discovery. Drug Dev. Res. 56:2002;194-200.
6. D'Andrea M.R., Nagele R.G., Wang H.-Y., Lee D.H.S. Epitope recovery immunohistochemical methods insure intracellular localization of Aβ42 within Alzheimer's disease pyramidal neurons. Neurosci. Lett. 333:(3):2002;163-166.
7. D'Andrea M.R., Nagele R.G., Wang H.-Y., Peterson P.A., Lee D.H.S. Evidence for a neuronal origin of amyloid plaques in Alzheimer's disease. Histopathology. 38:2001;120-134.
8. D'Andrea M.R., Reiser P.A., Gumula N.A., Hertzog B.M., Andrade-Gordon P. Application of triple-label immunohistochemistry to characterize inflammation in Alzheimer's disease brains. Biotech. & Histochem. 76:2001;97-106.
9. Doi-Yi R., Kitamoto T., Tateishi J. Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatment. Acta Neuropathol. 82:1991;260-265.
10. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156:2000;15-20.
11. Ikeda S., Allsop D., Gleener G.G. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Lab. Invest. 60:(1):1989;113-122.
12. Iwamoto N., Nishiyama E., Ohwada J., Aria H. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci. Lett. 177:(1-2):1994;23-26.
13. Kitamoto T., Ogomori K., Tateishi J., Prusiner S.B. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab. Invest. 57:1987;230-236.
14. Liberski P.P., Yanagihara R., Brown P., Kordek R., Kloszewska I., Bratosiewicz J., Gajdusek D.C. Microwave treatment enhances the immunostaining of amyloid deposits in both the transmissible and non-transmissible brain amyloidoses. Neurodegeneration. 5:(1):1996;95-99.
15. Nagele R.G., D'Andrea M.R., Lee H., Venkataraman V., Wang H.-Y. Astrocytes accumulate Abeta42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003;. in press.
16. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., Masliah E. Abnormal distribution of the non-Aβ component of Alzheimer's disease amyloid precursor/α-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab. Invest. 78:(9):1998;1169-1177.
17. Vinters H.V., Pardridge W.M., Secor D.L., Ishii N. Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am. J. Pathol. 133:1988;150-162.
18. Wang H.-Y., D'Andrea M.R., Nagele R.G. Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells. Neurobiol. Aging. 23:(2):2002;213-223.
19. Zhang Y., McLaughlin R., Goodyer C., LeBlanc A. Selective cytotoxicity of intracellular amyloid B peptide1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156:(3):2002;519-529.